Glaxosmithkline, LLC Research and Development in Biotechnology (except Nanobiotechnology) Contracts in NORTH CAROLINA
Federal Research and Development in Biotechnology (except Nanobiotechnology) contracts by Glaxosmithkline, LLC performed in NORTH CAROLINA (NC) - NAICS 541714
Three-Dimensional Spending Analysis
This page provides a granular three-dimensional view of Glaxosmithkline, LLC's federal contracting activity at the intersection of industry sector and geographic location. Glaxosmithkline, LLC holds 0 Research and Development in Biotechnology (except Nanobiotechnology) sector contracts valued at $0 that are performed in NORTH CAROLINA. Understanding the geographic and sector concentration of contractor activity helps identify regional economic dependencies on federal procurement and reveals where taxpayer dollars flow at the most specific level.
Overview
Total Contract Value: $0
Contract Count: 0
Average Contract Size: $0
Competition Rate: 0%
Small Business Rate: 0%
Frequently Asked Questions
How many Research and Development in Biotechnology (except Nanobiotechnology) contracts does Glaxosmithkline, LLC have in NORTH CAROLINA?
Glaxosmithkline, LLC has 0 Research and Development in Biotechnology (except Nanobiotechnology) contracts performed in NORTH CAROLINA worth a combined $0.
What is the average Research and Development in Biotechnology (except Nanobiotechnology) contract size for Glaxosmithkline, LLC in NORTH CAROLINA?
The average Research and Development in Biotechnology (except Nanobiotechnology) contract size for Glaxosmithkline, LLC in NORTH CAROLINA is $0.
Which agencies award Research and Development in Biotechnology (except Nanobiotechnology) work to Glaxosmithkline, LLC in NORTH CAROLINA?
Agency data is being compiled.
Are Glaxosmithkline, LLC's Research and Development in Biotechnology (except Nanobiotechnology) contracts in NORTH CAROLINA competitively awarded?
0% of these contracts were competitively awarded.